|
CONCENTRATIONS (Details Textual) (USD $)
|
3 Months Ended | 6 Months Ended | 6 Months Ended | 3 Months Ended | 6 Months Ended | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Jun. 30, 2012
|
Jun. 30, 2011
|
Jun. 30, 2012
|
Jun. 30, 2011
|
Dec. 31, 2011
|
Jun. 30, 2012
Subsequent Event [Member]
|
Apr. 05, 2012
Subsequent Event [Member]
|
Jun. 30, 2012
Customer 1 [Member]
|
Jun. 30, 2011
Customer 1 [Member]
|
Jun. 30, 2012
Customer 1 [Member]
|
Jun. 30, 2011
Customer 1 [Member]
|
Jun. 30, 2012
Customer 2 [Member]
|
Jun. 30, 2011
Customer 2 [Member]
|
Jun. 30, 2012
Customer 3 [Member]
|
Jun. 30, 2011
Customer 3 [Member]
|
Jun. 30, 2012
Customer 4 [Member]
|
Jun. 30, 2011
Customer 4 [Member]
|
|
| Entity Wide Revenue Major Customer Percentage | 15.00% | 15.00% | 10.00% | 13.00% | |||||||||||||
| Entity Wide Receivable Major Customer Percentage | 9.00% | 12.00% | 9.00% | 10.00% | 8.00% | 10.00% | 8.00% | 9.00% | |||||||||
| Net Revenue, Percentage | 75.00% | 82.00% | 76.00% | 80.00% | |||||||||||||
| Common Stock, Shares, Issued (in shares) | 4,570,000 | 4,570,000 | 4,560,000 | 5,000 | |||||||||||||
| Common Stock Issued, Fair Value (in dollars) | $ 12,000 | ||||||||||||||||
| Subsequent Event, Description | In July 2012, the Company received approved SFDA registration certificate for proprietary homecare medical CPAP product of Model DHR-CPAP-C5. The certificate is valid until July 1, 2016 and allows the Company to sell the products in mainland China. | The Company issued 5,000 shares to an investor relationship consultant on April 5, 2012 pursuant to a consulting agreement signed on January 9, 2012. The fair value of the shares granted on April 5, 2012 was approximately $12,000 based on the closing price on that date.On April 23, 2012, the Company signed a strategic cooperation agreement with Timesco of London Ltd., to be its exclusive distributor in mainland China for Timesco''''s entire laryngoscope Optima series of products in the next three years. | |||||||||||||||